F10 and kidney failure: With relation to the patients with renal failure, it was observed that management was in line with ACCP recommendations, which advise adjusting posology for patients with creatinine clearance < 30 mL/min, since there is increased exposure to the medication and risk of bleeding due to factor Xa build up.